Herbert Loong: We need to address the issue of clincial trials disparity in AYA Oncology
Herbert Loong shared on LinkedIn:
“We need to address the issue of clincial trials disparity in AYA Oncology. Historically we have arbitrarily set inclusion cutoffs based on age which has been detrimental to recruitment & accessibility of clinical trials. Work also being done for telemedicine and specificend points for AYA population.”
Source: Herbert Loong/LinkedIn
OncoDaily
Dr. Herbert H. F. Loong is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK), with additional roles as Deputy Medical Director of the Phase 1 Clinical Trials Centre and founder of the Prince of Wales Hospital Adult Sarcoma Multidisciplinary Team. Dr. Loong has co-founded key organizations like the Asia Pacific Oncology Drug Development Consortium (APODDC) and the Asia Pacific Coalition Against Lung Cancer (APCLC). His involvement in international oncology bodies, including ASCO and IASLC, underscores his commitment to advancing cancer research and treatment on a global scale.